ANTHROPOMETRIC AND SUBCLINICAL CHARACTERISTICS IN CARDIAC FAILURE PATIENTS WITH CACHEXIA IN HO CHI MINH CITY UNIVERSITY MEDICAL CENTER

Phước Thành Phạm 1, Cao Ngọc Điệp Ngô 1, Cao Ngọc Điệp Ngô 1, Vĩnh Niên Lâm 2,
1 University of Medicine and Pharmacy at Ho Chi Minh City hospital
2 University of Medicine and Pharmacy at Ho Chi Minh City

Main Article Content

Abstract

Aims: The aim of the present study is to determine the frequency of cachectic cardiac patients and their anthropometric and subclinical characteristics, hospitalized in UMC. Methods: A cross-sectional study of 60 patients with heart failure 6 months admitted to Cardiology and Interventional Cardiology from August 2021 to February 2023 with EF <40%. Results: We enrolled 60 patients with EF <40%. All patients underwent a standardized questionnaire and measurement of body compositions. Cachexia is present in 16 (26.7%) of 60 patients. Among them, 10 (62.5%) of 16 have the BMI between 18.5 and 25, and belong to over 60 years-old group. There is a significant difference in age between male cachectic and non-cachectic cardiac patients. Moreover, they have lower hand-grip strength, smaller arm circumference, free-fat mass and visceral fat. Conclusion: Cachectic cardiac patients have less strength, less muscle mass which might impact the functional capacity characterized by hand-grip strength, and other prominent nutritional signs.

Article Details

References

1. Nguyễn Thị Xuân Thuỷ và CS, Nghiên cứu tình trạng suy mòn và rối loạn điện giải ở bệnh nhân suy tim giai đoạn cuối ở BV Đà Nẳng, 2013-2014.
2. Adam Rahman, Malnutrition and Cachexia in Heart Failure, Journal of Parenteral and Enteral Nutrition, Volume 40 Number 4, May 2016.
3. Anker SD, Coats AJ. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest. 1999 Mar;115(3):836-47.
4. Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003 Mar 29;361(9363):1077-83.
5. Argilés JM, Anker SD, Consensus on cachexia definitions. J Am Med Dir Assoc. 2010;11:229–230
6. Dos Santos L, Cyrino ES, Antunes M, Santos DA, Sardinha LB. Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle function. J Cachexia Sarcopenia Muscle 2017; 8:245–250.
7. Emami, A., Saitoh, M., Valentova, M., Sandek, A., Evertz, R., Ebner, N., … von Haehling, S. (2018). Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). European Journal of Heart Failure.
8. Lakshman Chandrashekhar Iyer, K. Vaishali, Abraham Samuel Babu, Prevalence of sarcopenia in heart failure: A systematic review, Indian Heart Journal, Volume 75, Issue 1, 2023, Pages 36-42, ISSN 0019-4832.